Skip to content
NBlaz – Lifestyle
Author:
Haisco Pharmaceutical Group Co., Ltd.
Haisco’s Class 1 Innovative Drug Ciprocopan Succinate Tablets Approved in China, Offering a New Treatment Option for Patients With PNH
July 23, 2026
Haisco Enters into Exclusive License Agreement with Nuvectis for Two Drug Candidates in Oncology and Complement Indications
June 23, 2026
Haisco Announces Licensing and Research Collaboration Agreement with Lilly to Develop Innovative Medicines Across Multiple Therapeutic Areas
June 1, 2026